The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $141.66

Today's change+16.87 +13.52%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $141.66

Today's change+16.87 +13.52%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc Hits New 100-day High

USANA Health Sciences Inc closed up sharply Wednesday, rallying (U.S.)$16.87 or 13.52% to (U.S.)$141.66 and setting a new 100-day high. Over the last five days, shares have gained 13.75% and 10.89% year to date. Shares have outperformed the S&P 500 by 9.36% during the last year.

Key company metrics

  • Open(U.S.) $129.00
  • Previous close(U.S.) $124.79
  • High(U.S.) $142.96
  • Low(U.S.) $127.42
  • Bid / Ask(U.S.) $140.00 / (U.S.) $141.00
  • YTD % change+10.89%
  • Volume328,390
  • Average volume (10-day)86,856
  • Average volume (1-month)92,992
  • Average volume (3-month)103,218
  • 52-week range(U.S.) $92.00 to (U.S.) $176.88
  • Beta1.13
  • Trailing P/E19.02×
  • P/E 1 year forward15.59×
  • Forward PEG1.56×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.45
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.35%

Based on its net profit margin of 10.35%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201604/02/2016Jan 02, 201601/02/2016Oct 03, 201510/03/2015Jul 04, 201507/04/2015
Revenue240233233233
Total other revenue--------
Total revenue240233233233
Gross profit198192192193
Total cost of revenue43404140
Total operating expense207197195194
Selling / general / administrative164157154154
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income34353839
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax33363839
Income after tax22242625
Income tax, total11121313
Net income22242625
Total adjustments to net income--------
Net income before extra. items22242625
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22242625
Inc. avail. to common incl. extra. items22242625
Diluted net income22242625
Dilution adjustment------0
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share1.771.831.921.92
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.771.831.921.92